A citation-based method for searching scientific literature

Paul F Mercer, Robin H Johns, Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, David C J Howell, Robin J McAnulty, Anuk Das, Andrew J Thorley, Terry D Tetley, Oliver Eickelberg, Rachel C Chambers. Am J Respir Crit Care Med 2009
Times Cited: 80







List of co-cited articles
858 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury.
Chris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, Paul F Mercer, Y C Gary Lee, Naftali Kaminski, John Morser, Joseph M Post, Toby M Maher, Andrew G Nicholson,[...]. J Clin Invest 2009
223
31

Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis.
David C J Howell, Robin H Johns, Joseph A Lasky, Bin Shan, Chris J Scotton, Geoffrey J Laurent, Rachel C Chambers. Am J Pathol 2005
159
27

Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.
R Gisli Jenkins, Xiao Su, George Su, Christopher J Scotton, Eric Camerer, Geoffrey J Laurent, George E Davis, Rachel C Chambers, Michael A Matthay, Dean Sheppard. J Clin Invest 2006
231
18

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
17

CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.
Bethany B Moore, Jill E Kolodsick, Victor J Thannickal, Kenneth Cooke, Thomas A Moore, Cory Hogaboam, Carol A Wilke, Galen B Toews. Am J Pathol 2005
334
16

Protection from pulmonary fibrosis in the absence of CCR2 signaling.
B B Moore, R Paine, P J Christensen, T A Moore, S Sitterding, R Ngan, C A Wilke, W A Kuziel, G B Toews. J Immunol 2001
253
15

Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
M Suga, K Iyonaga, H Ichiyasu, N Saita, H Yamasaki, M Ando. Eur Respir J 1999
126
15


The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
J S Munger, X Huang, H Kawakatsu, M J Griffiths, S L Dalton, J Wu, J F Pittet, N Kaminski, C Garat, M A Matthay,[...]. Cell 1999
12

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
Roderick J Phillips, Marie D Burdick, Kurt Hong, Marin A Lutz, Lynne A Murray, Ying Ying Xue, John A Belperio, Michael P Keane, Robert M Strieter. J Clin Invest 2004
766
12

Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
Annika Andersson-Sjöland, Carolina García de Alba, Kristian Nihlberg, Carina Becerril, Remedios Ramírez, Annie Pardo, Gunilla Westergren-Thorsson, Moisés Selman. Int J Biochem Cell Biol 2008
260
12

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
882
12

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
12

CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis.
Mehrnaz Gharaee-Kermani, Robert E McCullumsmith, Israel F Charo, Steven L Kunkel, Sem H Phan. Cytokine 2003
91
11

Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation.
Gerald S Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey E Lukashev, Paul H Weinreb, Kenneth J Simon, Kyungmin Hahm, Normand E Allaire, Nicola J Rinaldi,[...]. Am J Respir Crit Care Med 2008
281
11

Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis.
Harikrishna Tanjore, Xiaochuan C Xu, Vasiliy V Polosukhin, Amber L Degryse, Bo Li, Wei Han, Taylor P Sherrill, David Plieth, Eric G Neilson, Timothy S Blackwell,[...]. Am J Respir Crit Care Med 2009
296
11

Role of thrombin in pulmonary fibrosis.
N A Hernández-Rodríguez, A D Cambrey, N K Harrison, R C Chambers, A J Gray, A M Southcott, R M duBois, C M Black, M F Scully, R J McAnulty. Lancet 1995
109
11


Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation.
Olivier P Blanc-Brude, Fabienne Archer, Patricia Leoni, Claudia Derian, Steven Bolsover, Geoffrey J Laurent, Rachel C Chambers. Exp Cell Res 2005
76
11

Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Malgorzata Wygrecka, Grazyna Kwapiszewska, Ewa Jablonska, Susanne von Gerlach, Ingrid Henneke, Dariusz Zakrzewicz, Andreas Guenther, Klaus T Preissner, Philipp Markart. Am J Respir Crit Care Med 2011
60
15

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
299
11

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
11

Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis.
I Kotani, A Sato, H Hayakawa, T Urano, Y Takada, A Takada. Thromb Res 1995
146
10


Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.
Antje Moeller, Sarah E Gilpin, Kjetil Ask, Gerard Cox, Deborah Cook, Jack Gauldie, Peter J Margetts, Laszlo Farkas, Julian Dobranowski, Colm Boylan,[...]. Am J Respir Crit Care Med 2009
352
10

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix.
Kevin K Kim, Matthias C Kugler, Paul J Wolters, Liliane Robillard, Michael G Galvez, Alexis N Brumwell, Dean Sheppard, Harold A Chapman. Proc Natl Acad Sci U S A 2006
895
10

WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.
Melanie Königshoff, Monika Kramer, Nisha Balsara, Jochen Wilhelm, Oana Veronica Amarie, Andreas Jahn, Frank Rose, Ludger Fink, Werner Seeger, Liliana Schaefer,[...]. J Clin Invest 2009
387
10

Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis.
Christopher P Baran, Judy M Opalek, Sara McMaken, Christie A Newland, James M O'Brien, Melissa G Hunter, Benjamin D Bringardner, Martha M Monick, David R Brigstock, Paul C Stromberg,[...]. Am J Respir Crit Care Med 2007
118
10

Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
Mark S Wilson, Satish K Madala, Thirumalai R Ramalingam, Bernadette R Gochuico, Ivan O Rosas, Allen W Cheever, Thomas A Wynn. J Exp Med 2010
441
10

Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis.
Thomas H Sisson, Michael Mendez, Karen Choi, Natalya Subbotina, Anthony Courey, Andrew Cunningham, Aditi Dave, John F Engelhardt, Xiaoming Liu, Eric S White,[...]. Am J Respir Crit Care Med 2010
294
10


New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis.
Lei Sun, Marisa C Louie, Kevin M Vannella, Carol A Wilke, Ann Marie LeVine, Bethany B Moore, Thomas P Shanley. Am J Physiol Lung Cell Mol Physiol 2011
163
10

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Antje Prasse, Dmitri V Pechkovsky, Galen B Toews, Wolfgang Jungraithmayr, Florian Kollert, Torsten Goldmann, Ekkehard Vollmer, Joachim Müller-Quernheim, Gernot Zissel. Am J Respir Crit Care Med 2006
287
10

PAR-1-dependent and PAR-independent pro-inflammatory signaling in human lung fibroblasts exposed to thrombin.
Alejandro Ortiz-Stern, Xiaoling Deng, Natalia Smoktunowicz, Paul F Mercer, Rachel C Chambers. J Cell Physiol 2012
25
32

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
10

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.
Jason R Rock, Christina E Barkauskas, Michael J Cronce, Yan Xue, Jeffrey R Harris, Jiurong Liang, Paul W Noble, Brigid L M Hogan. Proc Natl Acad Sci U S A 2011
591
10

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara Jones, Rajesh Jagirdar, Tracy R Luckhardt, Jeffrey C Horowitz, Subramaniam Pennathur, Fernando J Martinez, Victor J Thannickal. Nat Med 2009
573
8

Anticoagulant therapy for idiopathic pulmonary fibrosis.
Hiroshi Kubo, Katsutoshi Nakayama, Masaru Yanai, Tomoko Suzuki, Mutsuo Yamaya, Mika Watanabe, Hidetada Sasaki. Chest 2005
297
8

Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis.
Kevin K Kim, Ying Wei, Charles Szekeres, Matthias C Kugler, Paul J Wolters, Marla L Hill, James A Frank, Alexis N Brumwell, Sarah E Wheeler, Jordan A Kreidberg,[...]. J Clin Invest 2009
310
8

Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis.
Joëlle Marchal-Sommé, Yurdagul Uzunhan, Sylvain Marchand-Adam, Dominique Valeyre, Vassili Soumelis, Bruno Crestani, Paul Soler. J Immunol 2006
123
8

Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis.
Brigham C Willis, Janice M Liebler, Katherine Luby-Phelps, Andrew G Nicholson, Edward D Crandall, Roland M du Bois, Zea Borok. Am J Pathol 2005
675
8


Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice.
Ichiro Inoshima, Kazuyoshi Kuwano, Naoki Hamada, Naoki Hagimoto, Michihiro Yoshimi, Takashige Maeyama, Akira Takeshita, Shiro Kitamoto, Kensuke Egashira, Nobuyuki Hara. Am J Physiol Lung Cell Mol Physiol 2004
96
8

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
D C Howell, N R Goldsack, R P Marshall, R J McAnulty, R Starke, G Purdy, G J Laurent, R C Chambers. Am J Pathol 2001
135
8

Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
Andreas Günther, Norbert Lübke, Monika Ermert, Ralph T Schermuly, Norbert Weissmann, Andreas Breithecker, Philipp Markart, Clemens Ruppert, Karin Quanz, Leander Ermert,[...]. Am J Respir Crit Care Med 2003
127
8

Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1.
R C Chambers, K Dabbagh, R J McAnulty, A J Gray, O P Blanc-Brude, G J Laurent. Biochem J 1998
124
8


Murine models of pulmonary fibrosis.
Bethany B Moore, Cory M Hogaboam. Am J Physiol Lung Cell Mol Physiol 2008
500
8


Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.
Fengrong Zuo, Naftali Kaminski, Elsie Eugui, John Allard, Zohar Yakhini, Amir Ben-Dor, Lance Lollini, David Morris, Yong Kim, Barbara DeLustro,[...]. Proc Natl Acad Sci U S A 2002
442
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.